TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19631705

Group type: EXPERIMENTAL
Intervention: 3% beta‐glucan‐enriched bread (betaGB)
Number of subjects: 14
Study: 17550132

Group type: EXPERIMENTAL
Intervention: 5-FU + low-dose CDDP (n=75)
Number of subjects: 155

Group type: COMPARATOR
Intervention: 5-FU (n=77)
Number of subjects: 155
Study: 15530928

Group type: EXPERIMENTAL
Intervention: Parent-imposed driving rules
Number of subjects: 24
Study: 10746493

Group type: EXPERIMENTAL
Intervention: Daily regimen: sulfadiazine (1 g twice a day) + 25 mg pyrimethamine + 15 mg folinic acid daily; n = 58
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Thrice-weekly regimen: sulfadiazine (1 g thrice a week) + 50 mg pyrimethamine + 15 mg folinic acid thrice a week; n = 66
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Not taking antiretroviral therapy
Number of subjects: 124
Study: 8930946

Group type: EXPERIMENTAL
Intervention: Goal Attainment Scaling (GAS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Alzheimer's Disease Assessment Scale‐Cognitive Section
Number of subjects: 15

Group type: COMPARATOR
Intervention: Global Deterioration Scale
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clinical Global Impression
Number of subjects: 15

Group type: COMPARATOR
Intervention: Mini‐Mental State Exam
Number of subjects: 15
Study: 1529149

Group type: EXPERIMENTAL
Intervention: Acyclovir 800 mg five times daily for 5 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 3900362

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2447325

Group type: EXPERIMENTAL
Intervention: Digitoxin
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (off digitoxin)
Number of subjects: 55
Study: 28956191

Group type: EXPERIMENTAL
Intervention: Presence of HSV-2 infection at enrolment
Number of subjects: 2750

Group type: EXPERIMENTAL
Intervention: Young age, being unmarried, having a partner with other partners
Number of subjects: 2750
Study: 27145828

Group type: EXPERIMENTAL
Intervention: Conventional periodontal therapy with Er,Cr:YSGG laser application (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional periodontal therapy (Group 1)
Number of subjects: 60
Study: 25913687

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Corn-soy blended flours (CSB)
Number of subjects: 33
Study: 23821423

Group type: EXPERIMENTAL
Intervention: Rehabilitation exercises (60 minutes, twice a week for 12 weeks)
Number of subjects: 70
Study: 20498389

Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg/d
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg/d
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Citalopram 30 mg/d
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study: 19021006

Group type: EXPERIMENTAL
Intervention: 1 gr i.v. paracetamol infusion 15 minutes before induction (Group I)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: i.v. Paracetamol infusion started 15 minutes before the end of surgery (Group II)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (Group III)
Number of subjects: 90
Study: 17233365

Group type: EXPERIMENTAL
Intervention: Oral ketamine administered at 8-hour intervals postoperatively
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 12699480

Group type: EXPERIMENTAL
Intervention: Discriminant Analysis (DA) with genetic variables only
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Discriminant Analysis (DA) with all related factors (gene and environmental factors)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANN) with all factors
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis of ANN inputs
Number of subjects: 256
Study: 10882621

Group type: EXPERIMENTAL
Intervention: Endotoxin (2 ng/kg LPS)
Number of subjects: 30
Study: 8938538

Group type: EXPERIMENTAL
Intervention: Presence of stainable hepatic iron
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Presence of stainable hepatic iron in hepatitis C
Number of subjects: 69
Study: 1402014

Group type: EXPERIMENTAL
Intervention: B subunit‐killed whole cell (BS‐WC)
Number of subjects: 3285

Group type: EXPERIMENTAL
Intervention: Killed whole cell only (WC)
Number of subjects: 3285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3285
Study: 3865492

Group type: EXPERIMENTAL
Intervention: Cefaclor (Kefolor), 20 mg/kg body weight b.i.d. for 10 days
Number of subjects: 77

Group type: COMPARATOR
Intervention: Untreated cases
Number of subjects: 77
Study: 30308699

Group type: EXPERIMENTAL
Intervention: Walking training with simultaneous cognitive demand (dual-task)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control walking training without cognitive distraction
Number of subjects: 50
Study: 29108736

Group type: EXPERIMENTAL
Intervention: Oral sucrose solution (2 mL of 88% sucrose)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (2 mL)
Number of subjects: 82
Study: 26707252

Group type: EXPERIMENTAL
Intervention: Tissucol(®) (fibrin glue)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No Tissucol(®) (control group)
Number of subjects: 60
Study: 23377167

Group type: EXPERIMENTAL
Intervention: Target-standardized predialysis SBP of 110 to 140 mm Hg
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Target-standardized predialysis SBP of 155 to 165 mm Hg
Number of subjects: 2000
Study: 23739436

Group type: EXPERIMENTAL
Intervention: Adaptol and Neyromidin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 20620200

Group type: EXPERIMENTAL
Intervention: MEDIUM sled velocity group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: FAST sled velocity group
Number of subjects: 40

Group type: COMPARATOR
Intervention: SLOW sled velocity group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MOVING trials
Number of subjects: 40
Study: 19040446

Group type: EXPERIMENTAL
Intervention: Chinbone augmentation with Bio-Gide membrane
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Chinbone augmentation without Bio-Gide membrane
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Bio-Oss augmentation with Bio-Gide membrane
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Combined augmentation techniques
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no augmentation techniques mentioned)
Number of subjects: 93
Study: 16882639

Group type: EXPERIMENTAL
Intervention: Class-based exercise program (group A)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Home-based exercise program (group B)
Number of subjects: 63
Study: 12811710

Group type: EXPERIMENTAL
Intervention: Superactivated charcoal (SAC) 75 g administered orally as a slurry in 8 oz of apple juice 3 hours after acetaminophen ingestion
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no SAC administered)
Number of subjects: 46
Study: 11154093

Group type: EXPERIMENTAL
Intervention: Pramipexole (PRX)
Number of subjects: 1756

Group type: EXPERIMENTAL
Intervention: Entacapone (ENT)
Number of subjects: 1756

Group type: EXPERIMENTAL
Intervention: Pergolide (PRG)
Number of subjects: 1756

Group type: EXPERIMENTAL
Intervention: Ropinirole (ROP)
Number of subjects: 1756

Group type: EXPERIMENTAL
Intervention: Tolcapone (TOL) 600 mg
Number of subjects: 1756

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1756
Study: 8957270

Group type: EXPERIMENTAL
Intervention: Semilente insulin
Number of subjects: 15

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 15
Study: 1530675

Group type: EXPERIMENTAL
Intervention: Product 1 (20 mg nifedipine)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Product 2 (20 mg nifedipine)
Number of subjects: 40
Study: 2862713

Group type: EXPERIMENTAL
Intervention: Ceftazidime (151 mg/kg every 8 hours for 12 days)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Gentamicin and Carbenicillin (6.3 mg/kg gentamicin every 8 hours, 450 mg/kg carbenicillin every 6 hours for 10 days)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 82

Group type: COMPARATOR
Intervention: Gentamicin and Carbenicillin
Number of subjects: 82
Study: 31485965

Group type: EXPERIMENTAL
Intervention: Medical weight management tools (partial meal replacements, recreation center vouchers, pharmacotherapy, commercial weight loss program vouchers, group behavioral weight loss program) for $5 or $10 monthly.
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: On-treatment participants (those actively using the tools).
Number of subjects: 428

Group type: COMPARATOR
Intervention: Registry-based comparators (usual care).
Number of subjects: 428
Study: 29729171

Group type: EXPERIMENTAL
Intervention: Vedolizumab infusions
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5-aminosalicylic acid (5-ASA)
Number of subjects: 38
Study: 27461877

Group type: EXPERIMENTAL
Intervention: Inert cream applied on the right hand during verbal session
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inert cream applied on the right hand during conditioning session
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Verbal suggestion to feel more pain
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Learning (conditioning)
Number of subjects: 18
Study: 23512770

Group type: EXPERIMENTAL
Intervention: UQDRIVE program (group education and support program)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Current clinical practice (no intervention)
Number of subjects: 131
Study: 22884841

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 20026457

Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg plus dexamethasone 20 mg
Number of subjects: 285

Group type: COMPARATOR
Intervention: Granisetron 3 mg plus dexamethasone 20 mg
Number of subjects: 285
Study: 18476957

Group type: EXPERIMENTAL
Intervention: Resiquimod 0.01%
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Resiquimod 0.03%
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Resiquimod 0.06%
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Resiquimod 0.1%
Number of subjects: 132
Study: 15705084

Group type: EXPERIMENTAL
Intervention: Darifenacin 7.5 mg
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg
Number of subjects: 395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Darifenacin
Number of subjects: 395
Study: 12571616

Group type: EXPERIMENTAL
Intervention: Physician using mercury sphygmomanometer
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Physician using Omron oscillometer
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Patient using Omron oscillometer
Number of subjects: 106
Study: 10472225

Group type: EXPERIMENTAL
Intervention: Midazolam sedation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no sedation or anaesthesia)
Number of subjects: 14
Study: 8551533

Group type: EXPERIMENTAL
Intervention: Neuromuscular biofeedback therapy
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Home exercise programs (post-therapy)
Number of subjects: 38
Study: 1946881

Group type: EXPERIMENTAL
Intervention: Angry face as CS+ (Conditioned Stimulus Positive) with shock as UCS (Unconditioned Stimulus)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Happy face as CS+ (Conditioned Stimulus Positive) with shock as UCS (Unconditioned Stimulus)
Number of subjects: 30
Study: 6794796

Group type: EXPERIMENTAL
Intervention: Methyldopa treatment
Number of subjects: 123

Group type: COMPARATOR
Intervention: Simple observation (Control)
Number of subjects: 123
Study: 31613129

Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program, 7 sessions
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Strong African American Families (SAAF) program, at least 5 of 7 sessions
Number of subjects: 472

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 472
Study: 28181738

Group type: EXPERIMENTAL
Intervention: High animal protein (AP) diet
Number of subjects: 44

Group type: COMPARATOR
Intervention: High plant protein (PP) diet
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both diets (AP and PP)
Number of subjects: 44
Study: 24750268

Group type: EXPERIMENTAL
Intervention: Light therapy (10000-lux light box, 30 min in the morning, three times a week for 4 weeks)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Routine care without light therapy
Number of subjects: 65
Study: 23803704

Group type: EXPERIMENTAL
Intervention: BHT‐3021 (0.3, 1.0, 3.0, and 6.0 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BHT‐3021
Number of subjects: 80

Group type: COMPARATOR
Intervention: BHT‐placebo
Number of subjects: 80
Study: 21995590

Group type: EXPERIMENTAL
Intervention: NOMAC/E2 (2.5 mg/1.5 mg) in a 24/4-day regimen
Number of subjects: 1591

Group type: COMPARATOR
Intervention: DRSP/EE (3 mg/30 μg) in a 21/7-day regimen
Number of subjects: 1591
Study: 19632409

Group type: EXPERIMENTAL
Intervention: Acupuncture and standard postoperative care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 90
Study: 16730170

Group type: EXPERIMENTAL
Intervention: 750-mg levofloxacin for 5 days
Number of subjects: 219

Group type: COMPARATOR
Intervention: 500-mg levofloxacin for 10 days
Number of subjects: 219
Study: 15323064

Group type: EXPERIMENTAL
Intervention: Olmesartan 20 mg/day
Number of subjects: 1777

Group type: EXPERIMENTAL
Intervention: Olmesartan 40 mg/day
Number of subjects: 1777
Study: 11251523

Group type: EXPERIMENTAL
Intervention: Desmopressin (40 microg, nasal spray)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Diclofenac (75 mg, intramuscularly)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Desmopressin and Diclofenac
Number of subjects: 61
Study: 9406292

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7618719

Group type: EXPERIMENTAL
Intervention: Epidural catheter threaded 3 cm into the epidural space
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Epidural catheter threaded 5 cm into the epidural space
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Epidural catheter threaded 7 cm into the epidural space
Number of subjects: 100
Study: 2801591

Group type: EXPERIMENTAL
Intervention: Multivitamin with 18 mg Fe
Number of subjects: 2

Group type: COMPARATOR
Intervention: Multivitamin without Fe
Number of subjects: 2
Study: 357128

Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Apomorphine-L-dopa-carbidopa
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 31220105

Group type: EXPERIMENTAL
Intervention: γ-PGA 1,500 mg for 4 weeks
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 28355688

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 183

Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 183
Study: 25886286

Group type: EXPERIMENTAL
Intervention: Multi-component school-based intervention including curriculum component, mandatory daily hand washing before lunch, extra cleaning of school toilets
Number of subjects: 8438

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 8438
Study: 23924918

Group type: EXPERIMENTAL
Intervention: Acute moderate-intensity endurance exercise before influenza vaccination
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham injection (control group)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Acute moderate-intensity endurance exercise
Number of subjects: 59
Study: 22525000

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined Behavioral Intervention
Number of subjects: 0
Study: 19409344

Group type: EXPERIMENTAL
Intervention: Transbond Plus
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond
Number of subjects: 24
Study: 17883522

Group type: EXPERIMENTAL
Intervention: Behavioral sleep modification (BSM)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo behavioral instructions
Number of subjects: 43
Study: 15181395

Group type: EXPERIMENTAL
Intervention: Stair Climbing (SC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Electrostimulation (ES)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Stair Climbing + Electrostimulation (SC+ES)
Number of subjects: 32
Study: 11834105

Group type: EXPERIMENTAL
Intervention: Hypohydration (‐4% body mass)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Euhydrated condition
Number of subjects: 14
Study: 9000189

Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiandrogens (NSAAs) plus luteinizing hormone-releasing hormone (LHRH) or orchiectomy
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiandrogens (NSAAs)
Number of subjects: 9

Group type: COMPARATOR
Intervention: LHRH or orchiectomy alone
Number of subjects: 9
Study: 8229530

Group type: EXPERIMENTAL
Intervention: Single dose (5 ml/kg) of protein-free synthetic surfactant (Exosurf) for rescue therapy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Single dose (5 ml/kg) of protein-free synthetic surfactant (Exosurf) for prophylactic therapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control subjects for prophylactic therapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control subjects for rescue therapy
Number of subjects: 89
Study: 3743614

Group type: EXPERIMENTAL
Intervention: tiapamil 300 mg thrice daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 29847387

Group type: EXPERIMENTAL
Intervention: General anesthesia with nerve blocks (bupivacaine and dexamethasone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spinal anesthesia with nerve blocks (mepivacaine and propofol sedation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General anesthesia with nerve blocks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spinal anesthesia with nerve blocks
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anesthesia and spinal anesthesia
Number of subjects: 0
Study: 26521158

Group type: EXPERIMENTAL
Intervention: Therapy devices with varying stability properties
Number of subjects: 25

Group type: COMPARATOR
Intervention: Flat rigid surface
Number of subjects: 25
Study: 24862029

Group type: EXPERIMENTAL
Intervention: Cerebellar gene coexpression modules (tan module)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cerebellar gene coexpression modules (light yellow module)
Number of subjects: 101
Study: 22481687

Group type: EXPERIMENTAL
Intervention: Eradication treatment plus proton pump inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proton pump inhibitors alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative control group (not infected with H. pylori)
Number of subjects: 0
Study: 19830661

Group type: EXPERIMENTAL
Intervention: Continuous double U-stitch gastrostomy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Previously published VAG technique (Control)
Number of subjects: 62
Study: 17637413

Group type: COMPARATOR
Intervention: 4-strand hamstring graft (4SHG)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 8-strand hamstring graft (8SHG)
Number of subjects: 76
Study: 16132805

Group type: EXPERIMENTAL
Intervention: Current use of hormone replacement therapy (HRT)
Number of subjects: 20671

Group type: EXPERIMENTAL
Intervention: Current use of hormone replacement therapy (HRT) in women aged 65+
Number of subjects: 20671

Group type: EXPERIMENTAL
Intervention: Current use of hormone replacement therapy (HRT) in women with BMI<30
Number of subjects: 20671

Group type: EXPERIMENTAL
Intervention: Current use of hormone replacement therapy (HRT) in women who regularly use aspirin or ibuprofen
Number of subjects: 20671
Study: 12006715

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Traditional Care
Number of subjects: 87
Study: 10456820

Group type: EXPERIMENTAL
Intervention: Intravenous ketoprofen
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 58
Study: 7551625

Group type: EXPERIMENTAL
Intervention: Structured psychiatric intervention consisting of health education, stress management/behavioral training, coping techniques, and psychosocial group support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active behavioral and cognitive coping strategies
Number of subjects: 0
Study: 2024846

Group type: EXPERIMENTAL
Intervention: Positive reinforcement (telephone discussions about OSA severity, benefits of nCPAP, and minimizing side effects) for new nCPAP users during the reinforcement period (3 months).
Number of subjects: 9

Group type: COMPARATOR
Intervention: No reinforcement for new nCPAP users during the nonreinforced period (3 months).
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Stable chronic nCPAP users (not a part of the randomized study).
Number of subjects: 9
Study: 7049817

Group type: EXPERIMENTAL
Intervention: Atenolol, 100 mg once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nifedipine, 10 mg 3 times daily
Number of subjects: 40
Study: 31821350

Group type: EXPERIMENTAL
Intervention: brief group-delivered motivational interviewing (bMI)
Number of subjects: 89

Group type: COMPARATOR
Intervention: brief group-delivered cognitive-behavioral therapy (bCBT)
Number of subjects: 89
Study: 27597425

Group type: EXPERIMENTAL
Intervention: EPLBD alone
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: EST with EPLBD
Number of subjects: 86
Study: 25727277

Group type: EXPERIMENTAL
Intervention: Individualized 45-minute multifaceted preoperative education
Number of subjects: 129

Group type: COMPARATOR
Intervention: Standard education
Number of subjects: 129
Study: 23820061

Group type: EXPERIMENTAL
Intervention: Experimental arm (treatment)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control arm (standard treatment)
Number of subjects: 39
Study: 22807609

Group type: EXPERIMENTAL
Intervention: Third Eye colonoscopy (TEC)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 345
Study: 19362552

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg/d for 8 weeks followed by 4 weeks of placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120